SAFE GROUP - 16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires: presentation of Professor Maestretti's clinical results on the Sycamore device

Safe

0.04 EUR -7.49%

• Charts
• News
• Analysen

Kaufen / Verkaufen

16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires: presentation of Professor Maestretti's clinical results on the Sycamore device

Fleurieux-sur-l'Arbresle - France – January 7, 2025 at 6pm. Safe announces that Professor Gianluca Maestretti, Head of Orthopaedics at the Freiburg Hospital, will present his clinical results on the Sycamore device at the 16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires, to be held in Nice on January 24, 2025.

Professor Maestretti, a recognized expert in orthopaedic surgery, will share his clinical observations on the use of Sycamore, an innovative device for the minimally invasive treatment of vertebral fractures. This presentation will be followed by a discussion with a panel of experts in interventional radiology, highlighting the growing impact of this technology in the field of spinal care.

This intervention is part of a wider demonstration of the device, which has already been presented at the XI MAMMI International Meeting - Diagnostic and Mini-invasive Spine Treatments - in Cagliari, Italy, from 8 to 10 December 2024. The event, organized by the Radiology Department of the Holy Trinity Hospital, was attended by internationally renowned specialists, reinforcing the recognition of the Sycamore device in the medical world.
The device, developed by Safe Orthopaedics, stands out for its ability to offer minimally invasive treatment of vertebral fractures, responding to a growing demand for solutions that are less traumatic and quicker for patients. This technology enables interventional radiologists to effectively treat vertebral fractures while minimizing risks and reducing recovery times.

The introduction of the Sycamore device into clinical practice marks a strategic step forward for Safe Orthopaedics, paving the way for a fast-growing specialty: interventional radiology. Minimally invasive treatments confirm Safe Orthopaedics' position as a key player in the innovation of therapeutic solutions for spinal pathologies.

About Safe Group

Safe Group is a French medical technology group that brings together Safe Orthopaedics, a pioneer in ready-to-use technologies for spine pathologies, and Safe Medical (formerly LCI Medical), a medical device subcontractor for orthopedic surgeries. The group employs approximately 100 people.
Safe Orthopaedics develops and manufactures kits combining sterile implants and ready-to-use instruments, available at any time to the surgeon. These technologies are part of a minimally invasive approach aimed at reducing the risks of contamination and infection, in the interest of the patient and with a positive impact on hospitalization times and costs. Protected by 15 patent families, SteriSpineTM kits are CE marked, and FDA approved. Safe Orthopaedics has subsidiaries in the United Kingdom, Germany, the United States.
For more information: www.safeorthopaedics.com

Safe Medical produces implantable medical devices and ready-to-use instruments. It has an innovation center and two production sites in France and in Tunisia, offering numerous industrial services: industrialization, machining, finishing and sterile packaging.
For more information: www.safemedical.fr

Contacts
SAFE GROUP                                                AELYON ADVISORS
investors@safeorthopaedics.com                        safe@aelyonadvisors.fr

Attachment

• Safe_PR_Maestretti